Does self-monitoring blood glucose improve outcomes in patients with type 2 diabetes not taking insulin?
Metadata[+] Show full item record
Does self-monitoring blood glucose improve outcomes in patients with type 2 diabetes not taking insulin? EVIDENCE-BASED ANSWER: In patients with type 2 diabetes (T2DM) not requiring insulin, self-monitoring of blood glucose (SMBG) has inconsistent effects on patient-oriented outcomes such as quality of life (QOL), hypoglycemia, and patient satisfaction. The effect of SMBG is also inconsistent on all-cause mortality and diabetic complications. SMBG is associated with small but clinically insignificant reductions in hemoglobin A1C (HbA1C) (SOR: C, metaanalysis of RCTs with disease-oriented outcomes).
Evidence-based practice 19, no. 10 (2016): 10-11